PUEROVITA BIOTECHNOLOGY
ACCESS TO EXTENDED LIFE – FOR ALL
About Us
We are a cross-disciplinary team passionate about driving change and disruption to the fundamentals of health – scientists at heart, and business people with a heart. We’re at the forefront of cutting-edge biotechnology, harnessing the power of multi-omics and patient data to create innovative solutions that empower health professionals.
Agespan, our flagship product, is a state-of-the-art medical platform that leverages the latest advancements in genomics, epigenetic, and artificial intelligence. Designed for healthcare professionals, Agespan offers precise disease risk predictions, personalized health recommendations, and tailored treatment insights. By analyzing omic data, lifestyle factors, and medical history, Agespan empowers healthcare providers to offer individualized care that can lead to early disease prevention and improved patient outcomes. With Agespan, the future of healthcare is personal, data-driven, and more effective.
Our mission is to revolutionize healthcare by providing professionals and individuals with the tools they need to proactively manage their health, prevent disease, and make data-driven decisions.
Join us on a journey towards a healthier, more personalized future.
“Finally someone is looking to go from research to commercial application on this important topic. My team and I are looking forward to the collaboration and development of this initiative”
Evandro Fei Fang
Assistant Professor, UiO
Head of Anti Aging Lab
Team
Valentin A. Normand
CEO/CSO
PhD Neuroscience
Valentin did his PhD in Neuroscience at the Kavli Institute for System Neuroscience and conducted research in the Moser Lab. He has a strong background both in biology and mathematical modeling. He is responsible for steering the company’s overall strategy, day-to-day operations, and scientific direction.
Alise D. Midtfjord
AI Team Lead
PhD AI / Machine Learning
With a PhD in Trustworthy AI and a background in medical physics, Alise is behind the AI rending our predictions possible. She is developing innovative algorithms to predict risks of complexe diseases by integrating multi-omics data together, with a special focus on uncertainty and explainability.
Irantzu Anzar
Senior Bioinformatician
PhD in Bioinformatics
Irantzu holds a PhD degree in bioinformatic from University of Oslo. Irantzu has a strong background in personalized immunotherapy and more than 9 years of commercial experience developing bioinformatic pipelines for NGS data analysis. She is behind our bioinformatics core, curating the data required for AI models
Severin Elvatun
AI Engineer
PhD Machine Learning
During his PhD, Severin worked on developing data-driven algorithms for personalized cancer risk prediction. Later, he transitioned into biomedical applications of Generative AI and Federated Learning. His expertise includes data analytics, AI engineering and software development.
David Volent Lindberg
Chief Technology officer
PhD Statistics / Mathematics
David did his PhD in Statistics at NTNU. He is the former AI lead in thhe research department of DNV GL, and a Senior AI consultant. David focuses on data security, platform development and quality statistics associated with our predictions, along leading other data scientists and software delvelopers.
Our advisors
Hilde Grønningsæter
Associate Professor, USN
PhD Health & Sport science.
Hilde is the founder of Humentor AS, a company screening and analysing biomarkers for health and job stress, with the goal of increasing health quality and productivity in individuals and organisations.
Rune Ougland
Urologist surgeon and resercher
MD, PhD
Konstantinos Palikaras
A.Prof - University of Athens
PhD Molecular Biology
Molecular biologist working with energy metabolism, autophagy and ageing. He obtained the ERC starting grant in 2022 to pursue his groundbreaking research.
Hilde Loge Nilsen
Professor UiO
PhD Molecular Biology
HIlde’s research focuses, among other things, on the quality control mechanisms that maintain function of DNA and RNA during aging and throughout the lifetime of cells and organisms.
Ingvild Myhre
iStyrelsen - CEO
Former CEO of Telenor Norge and board member of many companies, Hilde has a great experience in company development and management, and supports our team on these domains.
Board of directors
Inge Grini
Chairman
With more than 30 years of experience from Entrepreneurship, developing and commecialising advanced tech solutions and leadership withn AI & Analytics, Inge is supporting PueroVita in its overall development, marketing and growth, by leading our board.
Jan-Olav Styrvold
Board Member
Jan Olav sits in the board of several esablished companies and start-ups, and has strong experience in analytic leadership. He is the chairman of Digital Insight, a business angel network helping PueroVita Biotechnology on its path to success.
Kjersti Koller
Board Member
A seasoned leader with a 30-year record in healthcare, merging economic objectives with employee engagement and sound medical practices. A former CEO of health industry Kjersti’s experience spans negotiation, marketing, business planning, strategy, sales and influencing the pharmacy sector.
David Lindberg
Board Member
Aside from his involvement in the scientific development of our product, and acting CTO, David also represents Intellectual Labs AS in our board.
Your future long-lived health starts here
PueroVita Biotechnology creates personally and tailored deep insights into your very own biology to make you understand how you are aging and what you can do about it.
Because it is not the same for all people
